News Daily News Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute Michael O'Riordan October 10, 2017
News Daily News ACC Updates Recommendations for Non-statin Therapy Use for LDL-Cholesterol Lowering in Secondary Prevention Yael L. Maxwell September 06, 2017
News Daily News TAVR Use Triples in France, With Docs Treating Lower-Risk Patients Michael O'Riordan June 26, 2017
News Daily News Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint Michael O'Riordan February 03, 2017
News Daily News How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows Yael L. Maxwell January 31, 2017